Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17–48 (2023).

Article  PubMed  Google Scholar 

Woods-Burnham, L. et al. Psychosocial stress, glucocorticoid signaling, and prostate cancer health disparities in African American men. Cancer Health Disparities 4, https://companyofscientists.com/index.php/chd/article/view/169/188 (2023).

Powell, I. J., Vigneau, F. D., Bock, C. H., Ruterbusch, J. & Heilbrun, L. K. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men. Cancer Epidemiol. Biomark. Prev. 23, 1505–1511 (2014).

Article  Google Scholar 

Giri, V. N. et al. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev. Res. 2, 244–250 (2009).

Article  CAS  Google Scholar 

Chornokur, G., Dalton, K., Borysova, M. E. & Kumar, N. B. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 71, 985–997 (2011).

Article  PubMed  Google Scholar 

Loree, J. M. et al. Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncol. 5, e191870 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

McGinley, K. F., Tay, K. J. & Moul, J. W. Prostate cancer in men of African origin. Nat. Rev. Urol. 13, 99–107 (2016).

Article  CAS  PubMed  Google Scholar 

National Cancer Institute. SEER*Explorer: An interactive website for SEER cancer statistics. NCI https://seer.cancer.gov/statfacts/html/prost.html (2023).

Powell, I. J. Epidemiology and pathophysiology of prostate cancer in African-American men. J. Urol. 177, 444–449 (2007).

Article  PubMed  Google Scholar 

Milonas, D., Venclovas, Z. & Jievaltas, M. Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer. Cent. Eur. J. Urol. 72, 240–246 (2019).

Google Scholar 

Jahn, J. L., Giovannucci, E. L. & Stampfer, M. J. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen era. Int. J. Cancer 137, 2795–2802 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

He, T. & Mullins, C. D. Age-related racial disparities in prostate cancer patients: a systematic review. Ethn. Health 22, 184–195 (2017).

Article  PubMed  Google Scholar 

Guo, J. et al. Establishing a urine-based biomarker assay for prostate cancer risk stratification. Front. Cell Dev. Biol. 8, 597961 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Fenton, J. J. et al. Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force. JAMA 319, 1914–1931 (2018).

Article  PubMed  Google Scholar 

Barry, M. J. & Simmons, L. H. Prevention of prostate cancer morbidity and mortality: primary prevention and early detection. Med. Clin. North. Am. 101, 787–806 (2017).

Article  PubMed  Google Scholar 

Jansen, F. H. et al. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection. Eur. Urol. 57, 921–927 (2010).

Article  CAS  PubMed  Google Scholar 

Thompson, I. M. et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N. Engl. J. Med. 350, 2239–2246 (2004).

Article  CAS  PubMed  Google Scholar 

Barry, M. J. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N. Engl. J. Med. 344, 1373–1377 (2001).

Article  CAS  PubMed  Google Scholar 

Moyer, V. A. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157, 120–134 (2012).

Article  PubMed  Google Scholar 

Bibbins-Domingo, K., Grossman, D. C. & Curry, S. J. The US Preventive Services Task Force 2017 draft recommendation statement on screening for prostate cancer: an invitation to review and comment. JAMA 317, 1949–1950 (2017).

Article  PubMed  Google Scholar 

US Preventive Services Task Force.Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA 319, 1901–1913 (2018).

Article  Google Scholar 

American Cancer Society. American Cancer Society Recommendations for Prostate Cancer Early Detection. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html (2021).

Smith, R. A. et al. Cancer screening in the United States, 2018: a review of current american cancer society guidelines and current issues in cancer screening. CA Cancer J. Clin. 68, 297–316 (2018).

Article  PubMed  Google Scholar 

Prostate Cancer Foundation. The Prostate-Specific Antigen (PSA) Test. https://www.pcf.org/about-prostate-cancer/what-is-prostate-cancer/the-psa-test/ (2021).

Preston, D. M. et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology 56, 812–816 (2000).

Article  CAS  PubMed  Google Scholar 

Saini, S. PSA and beyond: alternative prostate cancer biomarkers. Cell. Oncol. 39, 97–106 (2016).

Article  CAS  Google Scholar 

Foundation, P. C. The Prostate-Specific Antigen (PSA) Test. https://www.pcf.org/about-prostate-cancer/what-is-prostate-cancer/the-psa-test/ (2022).

Shenoy, D., Packianathan, S., Chen, A. M. & Vijayakumar, S. Do African-American men need separate prostate cancer screening guidelines? BMC Urol. 16, 19 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Tsodikov, A. et al. Is prostate cancer different in Black men? Answers from 3 natural history models. Cancer 123, 2312–2319 (2017).

Article  PubMed  Google Scholar 

Shah, N., Ioffe, V. & Chang, J. C. Increasing aggressive prostate cancer. Can. J. Urol. 29, 11384–11390 (2022).

PubMed  PubMed Central  Google Scholar 

Becker, D. J. et al. The association of veterans’ PSA screening rates with changes in USPSTF recommendations. J. Natl Cancer Inst. 113, 626–631 (2021).

Article  PubMed  Google Scholar 

Danan, E. R., White, K. M., Wilt, T. J. & Partin, M. R. Reactions to recommendations and evidence about prostate cancer screening among White and Black male veterans. Am. J. Men’s Health 15, 15579883211022110 (2021).

Article  Google Scholar 

Wu, I. & Modlin, C. S. Disparities in prostate cancer in African American men: what primary care physicians can do. Cleve. Clin. J. Med. 79, 313–320 (2012).

Article  PubMed  Google Scholar 

Dess, R. T. et al. Association of Black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 5, 975–983 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Schumacher, F. R. et al. Race and genetic alterations in prostate cancer. JCO Precis. Oncol. 5, PO.21.00324 (2021).

PubMed  PubMed Central  Google Scholar 

Chowdhury-Paulino, I. M. et al. Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer Prostatic Dis. 25, 397–402 (2022).

Article  PubMed  Google Scholar 

Office of Disease Prevention and Health Promotion. Healthy People 2030. Social Determinants of Health. https://health.gov/healthypeople/priority-areas/social-determinants-health (2020).

Weprin, S. A. et al. Association of low socioeconomic status with adverse prostate cancer pathology among African American who underwent radical prostatectomy. Clin. Genitourin. Cancer 17, e1054–e1059 (2019).

Article  PubMed  Google Scholar 

Orom, H., Biddle, C., Underwood, W. III, Homish, G. G. & Olsson, C. A. Racial or ethnic and socioeconomic disparities in prostate cancer survivors’ prostate-specific quality of life. Urology 112, 132–137 (2018).

Article  PubMed  Google Scholar 

Lillie-Blanton, M. & Hoffman, C. The role of health insurance coverage in reducing racial/ethnic disparities in health care. Health Aff. 24, 398–408 (2005).

Article  Google Scholar 

Clouston, S. A. P. & Link, B. G. A retrospective on fundamental cause theory: state of the literature, and goals for the future. Annu. Rev. Sociol. 47, 131–156 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Kirby, J. B., Taliaferro, G. & Zuvekas, S. H. Explaining racial and ethnic disparities in health care. Med. Care 44, I64–I72 (2006).

Article  PubMed  Google Scholar 

Mahal, A. R., Mahal, B. A., Nguyen, P. L. & Yu, J. B. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance. Cancer 124, 752–759 (2018).

Article  PubMed  Google Scholar 

Watson, M. et al. Racial differences in prostate cancer treatment: the role of socioeconomic status. Ethn. Dis. 27, 201–208 (2017).

Article  PubMed  PubMed Central  Google Scholar 

El Khoury, C. J. & Clouston, S. A. P. Racial/ethnic disparities in prostate cancer 5-year survival: the role of health-care access and disease severity. Cancers 15, 4284 (2023).

Article